CONSERVATIVE TREATMENT OF CHRONIC VEIN DISEASES: FOCUS ON PHARMACOTHERAPY
- Authors: Bogachev V.Y.1, Boldin B.V1, Dzhenina O.V2, Lobanov V.N2
-
Affiliations:
- SBEI HPE RNSMU n.a. N.I. Pirogov of RMH
- First Phlebological Center
- Issue: No 10 (2016)
- Pages: 17-21
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/289022
- ID: 289022
Cite item
Open Access
Access granted
Abstract
This review presents the results of analysis of large epidemiologic and randomized clinical trials to assess the effectiveness of veno-active drugs for chronic vein diseases (CVD). Basic pathophysiological mechanisms and related manifestations of CVD are discussed in details. The authors note that in initial manifestations of CVD, convenience of use and price/quality criteria have a main influence on the choice of drug. In this regard, the preparation Aescusan, which contains a mixture of horse chestnut-derived triterpene saponins in combination with thiamine, is the best drug of choice. Taking into account the results of a large clinical study, which showed comparability of the therapeutic effect of Aescusan and compression therapy, Aescusan can be considered as a highly effective drag at different stages of CVD.
Keywords
Full Text
About the authors
V. Yu Bogachev
SBEI HPE RNSMU n.a. N.I. Pirogov of RMHMD, Prof., Head of the Department of Angiology and Vascular Surgery Moscow
B. V Boldin
SBEI HPE RNSMU n.a. N.I. Pirogov of RMHMoscow
O. V Dzhenina
First Phlebological CenterMoscow
V. N Lobanov
First Phlebological CenterMoscow
References
- Rabe E., Guex J.-J., Puskas A., Scuderi A., Fernandez Quesada F., The VCP Coordinators Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol 2012;31(2):105-15.
- Савельев В.С., Кириенко А.И., Богачев В.Ю. Хронические заболевания вен в Российской Федерации. Результаты международной исследовательской программы VEIN CONSULT. Флебология 2010;4(3):9-12.
- Jantet G. RELIEF study: first consolidated European data. Reflux assessment and quality of life improvement with micronized Flavonoids. Angiology.2000; 51:31-7.
- Eklof B, Perrin M., Delis K., Rutherford R. Update terminology of chronic venous disorders: the Vein Term Transatlantic Interdisciplinary Consensus Document. J. Vasc. Surg. 2009;21:498-501.
- Perrin M. Description and definition of venous symptoms in chronic venous disorders: a review. Medicographia. 2015;37(1):10-5.
- Bergan J., Schmid-Schonbein G., Coleridge-Smith P, Nicolaides A., Boisseau M., Eklof B. Chronic venous disease. N. Engl. J. Med. лечения тяжелых форм хронической венозной недостаточности [16, 17].2006;355:488-98.
- Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология. 2013;7(2):2-47.
- Guidelines Italian College of Phlebology Revision 2013 Int. Angiol. 2013;32(Suppl.1):1-139.
- Nicolaides A., Kakkos S., Eklof D., Perrin V., Nelzen O., Neglen P., Partsch H., Rybak Z. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. IntAngiol. 2014;33(2):87-208.
- Wittens C., Davies A.H., Bækgaard N., et al. Management of Chronic Venous Disease Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur. J. Vasc. Endovasc. Surg. 2015;49:678-737.
- Богачев В.Ю., Голованова О.В., Кузнецов А.Н. Особенности лечения хронических заболеваний вен в России. Предварительные результаты программы «VEIN ACT» Ангиология и сосудистая хирургия. 2015; 21(2):76-82.
- Богачев В.Ю., Голованова О.В., Кузнецов А.Н. Хронический венозный отек (С3 по СЕАР): Новые международные рекомендации и консенсусы. Ангиология и сосудистая хирургия. 2013;19(3):75-82.
- Perrin M., Ramelet A-A. Pharmacological Treatment of Primary Chronic Venous Disease: Rationale, Results and Unanswered Questions. Eur. J. Vasc. Endovasc. Surg. 2011;41:117-25.
- Богачев В.Ю., Голованова О.В., Кузнецов А.Н., Шекоян А.О. Биофлавоноиды и их значение в ангиологии. Фокус на диосмин. Ангиология и сосудистая хирургия 2013;19(3):75-82.
- Духанин А.С. Системные флебопротекторные препараты: от активного вещества к клиническому эффекту. Ангиология и сосудистая хирургия. 2014;20(4):84-92.
- Martinez M.J., Bonfill X., Moreno R.M., Vargas E., Capella D. Phlebotonics for venous insufficiency. Cochrane Database Syst. Rev. 2005: CD003229.
- Diehm C., Trampisch H.J., Lange S., Schmidt C. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency Lancet. 1996;347(8997):292-94.
Supplementary files
